/Investor DB

Thomvest Ventures — 2019 Investments

4 investments dated 2019 · listed companies and verified rows first · show all

Avalancheavalabs.orgin𝕏May 2019 · $33M

Ava Labs is a company building blockchain infrastructure and tools for creating and using finance applications.

Crypto & Web3Data & InfrastructureDeep TechFintechNew York City, US

Emin Gün Sirer(Founder)inEmin Gun Sirer(Founder)inCharley CooperinKevin Sekniqi(Founder)Maofan Ted Yin(Founder)Maofan Yin(Founder)

Co-investorsAnimoca BrandsAbstract VenturesCeras VenturesContinue CapitalInitialized CapitalLvna Capital+6 more

Credijustocredijusto.comin𝕏Aug 2019 · $42M

Covalto is a digital bank in Mexico that provides unsecured financing and investment services to businesses, offering flexible credit terms, fixed-rate investment products, and banking services without traditional collateral requirements.

Enterprise SoftwareFintechMexico City, MX

Allan Apoj Pascal(Executive Officer, Director)inDavid Poritz(Founder)in

Co-investorsAltai VenturesBreyer CapitalFour Acres CapitalSupernode VenturesBroadhaven Capital PartnersKaszek Ventures+3 more

ThousandEyesthousandeyes.comFeb 2019 · $50M

San Francisco, US

Ricardo Oliveira(Executive Officer, Director)inMohit Lad(Executive Officer, Director)in

BoardAaref Hilaly(Director)inStefan Dyckerhoff(Director)Sanjit Biswas(Director)Michael Tuchen(Director)

Co-investorsGV (Google Ventures)Sequoia CapitalTenaya CapitalUS Venture PartnersW Capital PartnersSalesforce Ventures+1 more

Wildtypewildtypefoods.comOct 2019

Wildtype grows salmon directly from fish cells using cellular agriculture, allowing production of seafood without wild-caught or farmed fish.

BiotechClimate TechFoodTechSan Francisco, US

Justin Kolbeck(Founder)inArye Elfenbein(Founder)inJustin Kolbeck Arye Elfenbein(Founder)

BoardJohn Melas-Kyriazi(Director)

Co-investorsBay Bridge Ventures ClimateCRV (Charles River Ventures)FootPrint CoalitionLifelyMaven VenturesMission Biocapital+21 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.